Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug combo tested to fight tuberculosis faster

NCT ID NCT05382312

Summary

This study tested a new drug, GSK3036656, combined with other TB medications to see how quickly it could kill tuberculosis bacteria in the lungs over 14 days. It involved 127 adults newly diagnosed with drug-sensitive TB. After the 14-day test period, all participants switched back to standard TB treatment for the remainder of their care.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • GSK Investigational Site

    Bellville, 7530, South Africa

Conditions

Explore the condition pages connected to this study.